# Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

> **NCT06932809** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 90 (estimated)

## Conditions studied

- Tauopathies

## Interventions

- **DRUG:** 18F-JSS20-183A PET
- **DIAGNOSTIC_TEST:** Brain MRI
- **DIAGNOSTIC_TEST:** Amyloid PET
- **BEHAVIORAL:** Neurological Assessments

## Key facts

- **NCT ID:** NCT06932809
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-09
- **Primary completion:** 2030-04
- **Final completion:** 2030-04
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06932809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06932809, "Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06932809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*